<div id="readability-page-1"><p>Private Trust Co. NA lifted its position in shares of  Stryker Corporation (NYSE:SYK - Free Report) by 157.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor  owned 19,920 shares of the medical technology company's stock after buying an additional 12,188 shares during the period. Stryker comprises  0.6% of Private Trust Co. NA's investment portfolio, making the stock its 20th largest position. Private Trust Co. NA's holdings in Stryker were worth $7,364,000 at the end of the most recent reporting period.</p><ul><li>3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most</li></ul><p>Other hedge funds also recently bought and sold shares of the company. Mid American Wealth Advisory Group Inc. bought a new position in  Stryker during the second quarter valued at approximately $26,000.  Elevation Point Wealth Partners LLC purchased a new stake in shares of  Stryker in the 2nd quarter valued at $28,000.  Sachetta LLC grew its holdings in shares of  Stryker by 58.7% during the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company's stock valued at $29,000 after purchasing an additional 27 shares during the last quarter.  Kilter Group LLC purchased a new position in  Stryker in the 2nd quarter worth $29,000.  Finally, Howard Hughes Medical Institute purchased a new position in  Stryker in the 2nd quarter worth $29,000. Institutional investors own  77.09% of the company's stock. </p><h2>Analyst Ratings Changes</h2><p>Several analysts have issued reports on SYK shares. Wells Fargo &amp; Company upped their price target on shares of Stryker from $452.00 to $456.00 and gave the company an &#34;overweight&#34; rating in a research report on Friday, November 14th. Evercore ISI dropped their target price on Stryker from $410.00 to $405.00 and set an &#34;outperform&#34; rating for the company in a report on Friday, October 31st. Redburn Partners  set a $420.00 price target on Stryker in a research report on Thursday, September 18th. Truist Financial lowered their price objective on Stryker from $400.00 to $392.00 and set a &#34;hold&#34; rating for the company in a research report on Thursday, December 18th. Finally, Sanford C. Bernstein  reissued an &#34;outperform&#34; rating on shares of Stryker in a research note on Monday, November 3rd. Thirteen analysts have rated the stock with a Buy rating and six have assigned  a Hold rating to the company. According to data from MarketBeat.com, Stryker currently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $431.84.</p><ul><li>Why Are Insiders Are Dumping Shares of Robinhood, Stryker, and Mercury Systems?</li></ul><p><b>Get Our Latest Stock Analysis on Stryker</b></p><h2>Stryker Stock Down 0.1%</h2><p>Shares of NYSE:SYK opened at $354.54 on Thursday. The stock's 50-day moving average is $364.48 and its 200 day moving average is $376.90. The company has a market cap of $135.58 billion, a PE ratio of 46.59, a P/E/G ratio of 2.51 and a beta of 0.89. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.85 and a quick ratio of 1.13. Stryker Corporation has a 1 year low of $329.16 and a 1 year high of $406.19. </p><ul><li>Beware the Death Cross: 3 Stocks Triggering This Spooky Signal</li></ul><p>Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings data on Friday, October 31st. The medical technology company reported $3.19 earnings per share for the quarter, topping analysts' consensus estimates of $3.13 by $0.06. The firm had revenue of $6.06 billion for the quarter, compared to analyst estimates of $6.04 billion. Stryker had a return on equity of 24.07% and a net margin of 12.07%.The business's quarterly revenue was up 10.2% compared to the same quarter last year. During the same period last year, the company earned $2.87 EPS.  Sell-side analysts anticipate that  Stryker Corporation will post 13.47 EPS for the current year. </p><h2>Stryker Increases Dividend</h2><p>The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be issued a $0.88 dividend. This represents a $3.52 annualized dividend and a yield of 1.0%. This is a boost from Stryker's previous quarterly dividend of $0.84. The ex-dividend date is Wednesday, December 31st. Stryker's dividend payout ratio (DPR) is 44.15%. </p><h2>Insider Activity at Stryker</h2><p>In other Stryker news, CFO Preston Wendell Wells sold 165 shares of the company's stock in a transaction dated Thursday, November 20th. The shares were sold at an average price of $365.88, for a total value of $60,370.20. Following the sale, the chief financial officer owned 6,694 shares in the company, valued at approximately $2,449,200.72. This represents a 2.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this link. Also, CAO William E. Berry, Jr. sold 1,953 shares of the firm's stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $365.49, for a total value of $713,801.97. Following the transaction, the chief accounting officer directly owned 2,833 shares of the company's stock, valued at approximately $1,035,433.17. This trade represents a 40.81% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 522,118 shares of company stock worth $185,381,932 over the last ninety days. 5.90% of the stock is owned by corporate insiders. </p><h2>About Stryker</h2> (Free Report)<p>Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.</p><h2>Read More</h2><ul><li>Five stocks we like better than Stryker</li><li>Do not delete, read immediately</li><li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li><li>Can Any Expenses Be Deducted From Capital Gains Tax?</li><li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li><li>Forget AI, This Will Be the Next Big Tech Breakthrough</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Stryker Right Now?</h2><p>Before you consider Stryker, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.</p><p>While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Private Trust Co. NA increased its stake in Stryker Corporation by 157.6% in the third quarter, now holding 19,920 shares worth $7,364,000. Stryker is the 20th largest position in Private Trust Co. NA's portfolio. Several other hedge funds also bought and sold shares of Stryker recently. Analysts have given Stryker a consensus rating of 'Moderate Buy' with an average price target of $431.84. Stryker's stock opened at $354.54, with a market cap of $135.58 billion.</p>

Private Trust Co. NA Boosts Stock Position in Stryker Corporation $SYK